160 related articles for article (PubMed ID: 37148324)
1. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy.
Rosiello G; Scilipoti P; Larcher A; Fallara G; Colandrea G; Basile G; Re C; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Marandino L; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
World J Urol; 2023 Jun; 41(6):1573-1579. PubMed ID: 37148324
[TBL] [Abstract][Full Text] [Related]
2. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.
Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
[TBL] [Abstract][Full Text] [Related]
4. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
[TBL] [Abstract][Full Text] [Related]
5. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
[TBL] [Abstract][Full Text] [Related]
6. Lymph node dissection in renal cell carcinoma.
Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
[TBL] [Abstract][Full Text] [Related]
7. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model.
Gershman B; Takahashi N; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
BJU Int; 2016 Nov; 118(5):742-749. PubMed ID: 26800148
[TBL] [Abstract][Full Text] [Related]
8. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
[TBL] [Abstract][Full Text] [Related]
9. When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow-up.
Capitanio U; Abdollah F; Matloob R; Suardi N; Castiglione F; Di Trapani E; Capogrosso P; Gallina A; Dell'Oglio P; Briganti A; Salonia A; Montorsi F; Bertini R
BJU Int; 2013 Jul; 112(2):E59-66. PubMed ID: 23795799
[TBL] [Abstract][Full Text] [Related]
10. Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancer.
Kuusk T; Zondervan P; Lagerveld B; Rosenzweig B; Raman A; Blok JM; de Bruijn R; Graafland N; Hendricksen K; Capitanio U; Minervini A; Ljungberg B; Horenblas S; Bex A
Urol Oncol; 2020 May; 38(5):521-525. PubMed ID: 32139289
[TBL] [Abstract][Full Text] [Related]
11. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
[TBL] [Abstract][Full Text] [Related]
12. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
J Urol; 2017 Mar; 197(3 Pt 1):574-579. PubMed ID: 27663461
[TBL] [Abstract][Full Text] [Related]
13. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
[TBL] [Abstract][Full Text] [Related]
14. The rationale and the role of lymph node dissection in renal cell carcinoma.
Capitanio U; Leibovich BC
World J Urol; 2017 Apr; 35(4):497-506. PubMed ID: 27364520
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma.
Nini A; Larcher A; Cianflone F; Trevisani F; Terrone C; Volpe A; Regis F; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
Front Surg; 2018; 5():26. PubMed ID: 29740587
[TBL] [Abstract][Full Text] [Related]
16. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
[TBL] [Abstract][Full Text] [Related]
17. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion.
Capitanio U; Deho' F; Dell'Oglio P; Larcher A; Capogrosso P; Nini A; Carenzi C; Freschi M; Briganti A; Salonia A; Montorsi F; Bertini R
World J Urol; 2016 Aug; 34(8):1139-45. PubMed ID: 26670425
[TBL] [Abstract][Full Text] [Related]
19. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
[TBL] [Abstract][Full Text] [Related]
20. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]